(Q42990644)

12 November 2017

1 reference

title

Pathogenesis of hepatitis B and C-induced hepatocellular carcinoma (English)

1 reference

12 November 2017

Idilman R

1

1 reference

12 November 2017

De Maria N

series ordinal

2

1 reference

12 November 2017

Colantoni A

series ordinal

3

1 reference

12 November 2017

Van Thiel DH

series ordinal

4

1 reference

12 November 2017

publication date

1 September 1998

1 reference

Journal of Viral Hepatitis

12 November 2017

published in

1 reference

12 November 2017

volume

5

1 reference

12 November 2017

issue

5

1 reference

12 November 2017

page(s)

285-299

1 reference

A meta-analysis of epidemiological studies on the combined effect of hepatitis B and C virus infections in causing hepatocellular carcinoma

12 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1046/J.1365-2893.1998.00116.X

Inactivation of p16INK4 in hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1365-2893.1998.00116.X

Recent advances in the molecular biology of hepatitis B virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1365-2893.1998.00116.X

Hepatitis B: global importance and need for control

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1365-2893.1998.00116.X

Hepatitis B and C viruses and primary liver cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1365-2893.1998.00116.X

Hepatitis B virus (HBV) and hepatocellular carcinoma. HBV DNA status and its implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1365-2893.1998.00116.X

Clonal Origin of Recurrent Hepatocellular Carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1365-2893.1998.00116.X

Sequences of hepatitis B virus DNA in the serum and liver of patients with acute benign and fulminant hepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1365-2893.1998.00116.X

Detection of Hepatitis B Virus-specific DNA in the Genomes of Human Hepatocellular Carcinoma and Liver Cirrhosis Tissues

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1365-2893.1998.00116.X

An in vitro system for infection with hepatitis B virus that uses primary human fetal hepatocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1365-2893.1998.00116.X

Molecular events in the pathogenesis of hepadnavirus-associated hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1365-2893.1998.00116.X

Chromosome aberrations and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1365-2893.1998.00116.X

Hepatitis B virus transactivator HBx uses a tumour promoter signalling pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1365-2893.1998.00116.X

HBx gene of hepatitis B virus induces liver cancer in transgenic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1365-2893.1998.00116.X

HBV X protein alters the DNA binding specificity of CREB and ATF-2 by protein-protein interactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1365-2893.1998.00116.X

p53 gene mutation and integrated hepatitis B viral DNA sequences in human liver cancer cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1365-2893.1998.00116.X

p53: at the crossroads of molecular carcinogenesis and risk assessment

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1365-2893.1998.00116.X

Selective G to T mutations of p53 gene in hepatocellular carcinoma from southern Africa

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1365-2893.1998.00116.X

Hepatitis B virus integration in a cyclin A gene in a hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1365-2893.1998.00116.X

Cyclin A and the retinoblastoma gene product complex with a common transcription factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1365-2893.1998.00116.X

RB tumor suppressor gene expression in hepatocellular carcinomas from patients infected with the hepatitis B virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1365-2893.1998.00116.X

Cellular and molecular mechanisms of hepatocarcinogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1365-2893.1998.00116.X

Expression of insulin-like growth factor II in hepatitis B, cirrhosis and hepatocellular carcinoma: its relationship with hepatitis B virus antigen expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1365-2893.1998.00116.X

Transforming growth factor alpha may be a physiological regulator of liver regeneration by means of an autocrine mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1365-2893.1998.00116.X

Transforming growth factor-alpha and human cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1365-2893.1998.00116.X

Transforming growth factor-alpha in human hepatocellular carcinoma and coexpression with hepatitis B surface antigen in adjacent liver

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1365-2893.1998.00116.X

Elevated levels of plasma transforming growth factor-beta in patients with hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1365-2893.1998.00116.X

Regulation of transforming growth factor-beta 1 expression by the hepatitis B virus (HBV) X transactivator. Role in HBV pathogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1365-2893.1998.00116.X

Tumor suppressor genes, growth factor genes, and oncogenes in hepatitis B virus-associated hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1365-2893.1998.00116.X

Hepatitis B injury, male gender, aflatoxin, and p53 expression each contribute to hepatocarcinogenesis in transgenic mice†

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1365-2893.1998.00116.X

Heterogeneity of hepatitis C virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1365-2893.1998.00116.X

Hepatitis C and B virus infections in hepatocellular carcinoma. Analysis of direct detection of viral genome in paraffin embedded tissues

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1365-2893.1998.00116.X

The long-term pathological evolution of chronic hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1365-2893.1998.00116.X

Macroregenerative nodules and hepatocellular carcinoma in forty-four sequential adult liver explants with cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1365-2893.1998.00116.X

Hepatitis C virus plus- and minus- strand RNA in hepatocellular carcinoma and adjoining nontumorous liver

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1365-2893.1998.00116.X

Expression of hepatitis C virus in hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1365-2893.1998.00116.X

Genotypic analysis of hepatitis C virus in American patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1365-2893.1998.00116.X

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1365-2893.1998.00116.X

10.1046/J.1365-2893.1998.00116.X

21 January 2018

Identifiers

DOI

1 reference

12 November 2017

1 reference